Huvitz Co Ltd
Huvitz Co Ltd operates with a debt-to-equity ratio of 0.73 and a current ratio of 1.07, indicating moderate liquidity risk. The company's price-to-book ratio is 0.75, and its price-to-tangible-book ratio is also 0.75, suggesting that the market values the company's tangible assets at a discount to its equity value. The company's negative net income of -4,973,820,460 KRW and negative operating income of -4,729,657,540 KRW indicate a lack of profitability. The company's return on equity (ROE) is -4.71%, and its return on assets (ROA) is -2.21%, both significantly below the industry median for Advanced Medical Equipment & Technology. The gross profit margin is 45.53% (53,736,403,210 KRW / 118,043,310,690 KRW), which is in line with the industry median, but the operating margin is -4.01% (-4,729,657,540 KRW / 118,043,310,690 KRW), indicating operational inefficiencies. Huvitz's revenue is primarily concentrated in its domestic market, with no disclosed international revenue segments. The company's revenue concentration in a single geographic region increases its exposure to local economic and regulatory risks. The company's revenue for the latest period is 118,043,310,690 KRW, and there are no disclosed growth projections for the current or next fiscal year. The company's free cash flow is negative at -7,265,051,230 KRW, and its capital expenditure is -7,618,972,960 KRW, indicating that the company is investing in its operations but is not generating sufficient cash to cover these investments. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may face challenges in meeting its short-term obligations. The company's valuation adjustments and dilution potential are not disclosed in the provided data. Recent events and filings do not provide specific details on the company's strategic initiatives or operational changes. The company's latest actual EPS is -461.00 KRW, and its latest actual revenue is 118,093,000,000 KRW, indicating a lack of earnings growth.
Business. Huvitz Co Ltd is a Korea-based company engaged in the manufacture and sale of ophthalmic medical devices, including automatic optometry machines, automatic lens meters, lens processing machines, reflectors, and ophthalmic diagnostic equipment.
Classification. Huvitz is classified in the Healthcare sector under the Advanced Medical Equipment & Technology industry with a confidence level of 0.92.
- Huvitz Co Ltd is a manufacturer of ophthalmic medical devices with a focus on domestic sales.
- The company is currently unprofitable, with negative operating and net income.
- The company's liquidity position is moderate, with a current ratio of 1.07 and a debt-to-equity ratio of 0.73.
- The company's ROE and ROA are significantly below the industry median, indicating poor returns on equity and assets.
- The company's revenue is concentrated in a single geographic region, increasing its exposure to local economic and regulatory risks.
- The company's free cash flow is negative, and its capital expenditure is high, indicating that the company is investing in its operations but is not generating sufficient cash to cover these investments.
- --
- ## RATIONALES
- Net cash is negative after subtracting total debt.